local_hospital

Centrum Leczenia MIGRE

Address
lock Available on a paid plan

Nervous System Diseases

At Centrum Leczenia MIGRE in Wroclaw, research in Nervous System Diseases focuses heavily on migraine and related pain disorders, including chronic migraine, episodic migraine, menstrual migraine, and trigeminal neuralgia. These studies are mainly designed to test new preventive and acute treatments, while also assessing safety, symptom control, and longer-term benefit.

  • Preventive care for chronic and episodic migraine in adults and children
  • Acute treatment options for migraine attacks and migraine pain relief
  • Research on trigeminal neuralgia pain management and tolerability
  • Studies in pediatric and adolescent migraine populations

The site contributes to a broad effort to improve how migraine is treated across age groups, with a strong emphasis on both effectiveness and patient safety.

Digestive System Diseases

Clinical research in Digestive System Diseases at this site centers on ulcerative colitis, including patients with moderately to severely active ulcerative colitis. The trials are aimed at evaluating whether new therapies can better control inflammation, improve clinical response, and support remission compared with established treatment options.

  • Testing new approaches for active ulcerative colitis
  • Comparing investigational medicines with standard care
  • Measuring treatment response and remission outcomes
  • Assessing safety and tolerability in inflammatory bowel disease

This work reflects an ongoing interest in improving treatment choices for people living with ulcerative colitis, especially those with more difficult-to-control disease.

Musculoskeletal Diseases

The Musculoskeletal Diseases portfolio includes studies in knee osteoarthritis, with research focused on easing joint pain and improving function. These trials are generally intended to evaluate whether new or repurposed treatments can reduce discomfort and support better day-to-day mobility for people affected by osteoarthritis.

  • Pain relief research in knee osteoarthritis
  • Evaluation of treatments that may improve joint symptoms
  • Studies of overall effectiveness and tolerability
  • Support for patients with chronic knee pain and stiffness

At Centrum Leczenia MIGRE, this area adds a practical focus on improving quality of life for patients with persistent knee osteoarthritis.

Nutritional and Metabolic Diseases

Research in Nutritional and Metabolic Diseases addresses overweight and obesity, including people with and without type 2 diabetes mellitus. The trials are designed to examine whether new treatments can help support weight loss and long-term weight management, while also considering safety and tolerability.

  • Weight-loss treatment research in overweight and obesity
  • Studies involving participants with and without type 2 diabetes
  • Assessment of sustained treatment benefit
  • Safety-focused evaluation of metabolic therapies

This area broadens the site’s clinical research beyond pain and inflammation, with attention to a major public health issue linked to long-term metabolic risk.

Site Overview

assignment
30
connected trials
corporate_fare
13
sponsors
science
16
IMPs

Activity Indicator

Last 6 months

1
Trials started
-67% vs previous period.
3
Trials started 6–12 months ago
30
Total trials linked
Highly Active
trending_downDeclining-67%
1
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status

Top 4 therapeutic areas and 15 of 16 IMPs, ranked by number of trials.

lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years
lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
12
Sponsors (total)
13
Active sponsors
6

Sponsor Network

Top 6 by active trials.

lock +5 more on a paid plan

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

lock +4 more on a paid plan

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 1 624 other sites in Poland

description
Trial volume
30
Outperforms 90% of sites
public
Therapeutic diversity
4areas
Outperforms 79% of sites
groups
Sponsor diversity
13sponsors
Outperforms 86% of sites

Therapeutic Area Benchmark — Poland

Select a therapeutic area to compare against other sites in Poland.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: Poland

Market Share

Country: Poland

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in Centrum Leczenia MIGRE

lock Showing 1 of 30 trials — the rest is available on a paid plan.

Trial Sponsor Phase Status Start Date End Date
A Multicenter, Open-label, Extension Study to Evaluate the Long-term Safety and Tolerability of Atogepant in Pediatric Subjects 6 to 17 years of age with MigraineAbbVie Deutschland GmbH & Co. KGPhase IIIRecruitingDec 2023

IMP list

lock Showing 1 of 16 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
Atogepant6Unknown2021-08-162025-06-23

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.